NIPT Test in Dubai: Non-Invasive Prenatal Testing

NIPT has a detection rate exceeding 99% for Down syndrome (Trisomy 21), making it the most accurate screening test available for this condition. For Trisomy 18 (Edwards syndrome), detection rates are approximately 97-99%, and for Trisomy 13 (Patau syndrome), approximately 92-99%. The false positive rate is very low, typically less than 0.1% for Trisomy 21. However, it is important to understand that NIPT is a screening test, not a diagnostic test, meaning a high-risk result should be confirmed with amniocentesis or CVS before any irreversible decisions are made.

NIPT can be performed from 10 weeks of gestation onwards. This is one of its key advantages over many other prenatal tests. At 10 weeks, there is sufficient cell-free fetal DNA (cfDNA) circulating in the mother's blood for accurate analysis. There is no upper gestational age limit, so if you missed the window for first-trimester combined screening, NIPT remains available throughout your pregnancy. Most women choose to have NIPT between 10 and 14 weeks to get early reassurance, but it can be performed at any point after 10 weeks.

NIPT is a screening test that uses a maternal blood sample to assess the probability of chromosomal conditions, while amniocentesis is a diagnostic test that extracts amniotic fluid using a needle inserted through the abdomen. NIPT is non-invasive and carries no risk of miscarriage, whereas amniocentesis carries a small miscarriage risk of approximately 0.1-0.3%. NIPT provides a risk assessment (low-risk or high-risk), while amniocentesis provides a definitive diagnosis. If NIPT returns a high-risk result, amniocentesis is typically recommended to confirm the finding before any clinical decisions are made. Read our comprehensive comparison in our NIPT vs amniocentesis guide.

Yes, most NIPT panels include fetal sex determination as part of the standard analysis because the test examines cell-free DNA fragments that include sex chromosome information. NIPT can accurately determine whether the baby is male or female from as early as 10 weeks of pregnancy, which is significantly earlier than ultrasound-based gender determination (typically reliable from 16-20 weeks). If you prefer not to know the sex, you can request that this information be withheld from your results. Gender determination via NIPT is highly accurate, exceeding 99% in most studies.

A high-risk NIPT result means the test detected an elevated probability of a specific chromosomal condition, but it does not confirm a diagnosis. Your obstetrician will discuss the result with you in detail and recommend confirmatory diagnostic testing, typically amniocentesis (from 15-16 weeks) or chorionic villus sampling (CVS, from 11-13 weeks). Genetic counseling is also offered to help you understand the implications and make informed decisions. It is important not to panic, as a small percentage of high-risk NIPT results are false positives. Confirmatory testing will provide a definitive answer.

Insurance coverage for NIPT in the UAE varies between providers and policy types. Many insurance plans cover NIPT for women aged 35 and older, those with abnormal first-trimester screening results, or those with other clinical risk factors. Some enhanced maternity packages include NIPT as a standard benefit regardless of age. We recommend contacting your insurance provider to check your specific coverage and any pre-authorization requirements. Our team can assist with insurance verification and provide documentation to support your claim if needed.

No, NIPT screens for specific chromosomal conditions and does not detect all genetic disorders. Standard NIPT panels screen for Trisomy 21, 18, and 13, along with sex chromosome aneuploidies. Extended panels may include screening for selected microdeletions such as DiGeorge syndrome (22q11.2 deletion). NIPT does not screen for single-gene disorders (such as cystic fibrosis or sickle cell disease), structural abnormalities, neural tube defects, or most rare genetic conditions. The anomaly scan at 20 weeks remains essential for detecting structural abnormalities, and carrier screening or other genetic tests may be recommended based on family history.

Yes, NIPT can be performed in twin pregnancies, though with some important differences compared to singleton pregnancies. For dichorionic (non-identical) twins, NIPT can screen for trisomies but cannot determine which twin is affected if a high-risk result is returned. For monochorionic (identical) twins, results apply to both babies as they share the same genetic material. The fetal fraction (amount of placental DNA in maternal blood) can be different in twin pregnancies, and there is a slightly higher chance of a no-call result requiring a repeat sample. Sex determination may also be limited in dichorionic twins. Your obstetrician will discuss these nuances with you.